Companies › DWTX
DOGWOOD THERAPEUTICS INC (DWTX)
Institutional ownership, SEC filings and insider activity
Sector: Healthcare & Pharma · SEC CIK 0001818844 · EDGAR filings · Updated 2026-06-17
DOGWOOD THERAPEUTICS INC (DWTX) has reported institutional ownership of 10.8%, with 13 institutional managers holding positions valued at $7.64M per the latest 13F reporting period. SEC filings include an active notice of delisting or failure to satisfy a continued listing rule (8-K Item 3.01), substantial-doubt (going concern) disclosure per the filings.
Latest updates
- 2026-06-17 — Current report (8-K) filed
- 2026-06-17 — Insider transaction reported (Form 4)
- 2026-06-17 — Insider transaction reported (Form 4)
- 2026-06-17 — Insider transaction reported (Form 4)
- 2026-06-17 — Insider transaction reported (Form 4)
- 2026-05-15 — SCHEDULE 13G filed
Institutional ownership overview
According to SEC 13F filings tracked by Sightfile, DOGWOOD THERAPEUTICS INC has 13 institutional holders and institutional ownership of 10.8%.
Insider activity
Insiders reported 2 transactions (0 buys, 0 sells) across 1 reporting insiders, with a net reported value of $0.
Data flags from SEC filings
Related companies
TherapeuticsMD Inc (TXMD) · VYNE THERAPEUTICS INC (VYNE) · QUOIN PHARMACEUTICALS LTD (QNRX) · Veru Inc (VERU) · MediciNova Inc (MNOV) · BIOHARVEST SCIENCES INC (BHST)
See full history, cross-references and alerts on SightfileData sources: SEC EDGAR (filings, 13F, FTD), aggregated by Sightfile. Page updated 2026-06-17.